Cargando…

Advances in nanomedicines for lymphatic imaging and therapy

Lymph nodes play a pivotal role in tumor progression as key components of the lymphatic system. However, the unique physiological structure of lymph nodes has traditionally constrained the drug delivery efficiency. Excitingly, nanomedicines have shown tremendous advantages in lymph node-specific del...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Pan, Tang, Haitian, Zheng, Yating, Xiong, Yongfu, Cheng, Hongwei, Li, Jingdong, Zhang, Yang, Liu, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463797/
https://www.ncbi.nlm.nih.gov/pubmed/37620846
http://dx.doi.org/10.1186/s12951-023-02022-x
_version_ 1785098315930533888
author He, Pan
Tang, Haitian
Zheng, Yating
Xiong, Yongfu
Cheng, Hongwei
Li, Jingdong
Zhang, Yang
Liu, Gang
author_facet He, Pan
Tang, Haitian
Zheng, Yating
Xiong, Yongfu
Cheng, Hongwei
Li, Jingdong
Zhang, Yang
Liu, Gang
author_sort He, Pan
collection PubMed
description Lymph nodes play a pivotal role in tumor progression as key components of the lymphatic system. However, the unique physiological structure of lymph nodes has traditionally constrained the drug delivery efficiency. Excitingly, nanomedicines have shown tremendous advantages in lymph node-specific delivery, enabling distinct recognition and diagnosis of lymph nodes, and hence laying the foundation for efficient tumor therapies. In this review, we comprehensively discuss the key factors affecting the specific enrichment of nanomedicines in lymph nodes, and systematically summarize nanomedicines for precise lymph node drug delivery and therapeutic application, including the lymphatic diagnosis and treatment nanodrugs and lymph node specific imaging and identification system. Notably, we delve into the critical challenges and considerations currently facing lymphatic nanomedicines, and futher propose effective strategies to address these issues. This review encapsulates recent findings, clinical applications, and future prospects for designing effective nanocarriers for lymphatic system targeting, with potential implications for improving cancer treatment strategies.
format Online
Article
Text
id pubmed-10463797
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104637972023-08-30 Advances in nanomedicines for lymphatic imaging and therapy He, Pan Tang, Haitian Zheng, Yating Xiong, Yongfu Cheng, Hongwei Li, Jingdong Zhang, Yang Liu, Gang J Nanobiotechnology Review Lymph nodes play a pivotal role in tumor progression as key components of the lymphatic system. However, the unique physiological structure of lymph nodes has traditionally constrained the drug delivery efficiency. Excitingly, nanomedicines have shown tremendous advantages in lymph node-specific delivery, enabling distinct recognition and diagnosis of lymph nodes, and hence laying the foundation for efficient tumor therapies. In this review, we comprehensively discuss the key factors affecting the specific enrichment of nanomedicines in lymph nodes, and systematically summarize nanomedicines for precise lymph node drug delivery and therapeutic application, including the lymphatic diagnosis and treatment nanodrugs and lymph node specific imaging and identification system. Notably, we delve into the critical challenges and considerations currently facing lymphatic nanomedicines, and futher propose effective strategies to address these issues. This review encapsulates recent findings, clinical applications, and future prospects for designing effective nanocarriers for lymphatic system targeting, with potential implications for improving cancer treatment strategies. BioMed Central 2023-08-24 /pmc/articles/PMC10463797/ /pubmed/37620846 http://dx.doi.org/10.1186/s12951-023-02022-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
He, Pan
Tang, Haitian
Zheng, Yating
Xiong, Yongfu
Cheng, Hongwei
Li, Jingdong
Zhang, Yang
Liu, Gang
Advances in nanomedicines for lymphatic imaging and therapy
title Advances in nanomedicines for lymphatic imaging and therapy
title_full Advances in nanomedicines for lymphatic imaging and therapy
title_fullStr Advances in nanomedicines for lymphatic imaging and therapy
title_full_unstemmed Advances in nanomedicines for lymphatic imaging and therapy
title_short Advances in nanomedicines for lymphatic imaging and therapy
title_sort advances in nanomedicines for lymphatic imaging and therapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463797/
https://www.ncbi.nlm.nih.gov/pubmed/37620846
http://dx.doi.org/10.1186/s12951-023-02022-x
work_keys_str_mv AT hepan advancesinnanomedicinesforlymphaticimagingandtherapy
AT tanghaitian advancesinnanomedicinesforlymphaticimagingandtherapy
AT zhengyating advancesinnanomedicinesforlymphaticimagingandtherapy
AT xiongyongfu advancesinnanomedicinesforlymphaticimagingandtherapy
AT chenghongwei advancesinnanomedicinesforlymphaticimagingandtherapy
AT lijingdong advancesinnanomedicinesforlymphaticimagingandtherapy
AT zhangyang advancesinnanomedicinesforlymphaticimagingandtherapy
AT liugang advancesinnanomedicinesforlymphaticimagingandtherapy